Browse treatments

…that could be used to modulate TLS in solid tumors for improved immunotherapy response.Ethics Approval This study was approved by the Univers…

…ative to tumor cells can identify patients likely to respond to immunotherapy or track responses over time. Development of a robust, reproduc…

…E, offering new opportunities to better understand responses to immunotherapy and combination chemotherapy strategies.…

…prognostic stratification and identifying patients resistant to immunotherapy. Targeting ST3GAL1-mediated sialylation may offer a novel strat…

… systematic misidentification of CD8 + T cells—key effectors in immunotherapy—raises concerns about conclusions drawn from scRNA-seq data alo…

…0 hyperbaric oxygen treatments. His chemotherapy was changed to immunotherapy. He made a complete recovery. In the beginning of his treatment…

…hway and generates TCF1(+) progenitor CD8(+) T cells to improve immunotherapy. Nat Immunol. 2024.Ethics Approval All animal work was performe…

… accuracy and consistency of TMB measurements, particularly for immunotherapy decision-making.Methods We analyzed 202 tumor samples from lung…

…ally leading to better clinical outcomes and better response to immunotherapy. However, the causal factors underlying this difference between…

…ncies and select solid tumors, making it an emerging target for immunotherapy. However, comprehensive analyses comparing CD70 expression betw…

…imodal conventional therapies such as surgery, radiotherapy and chemotherapy have shown limited results in glioma patients. Over the last de…

…lecular disparities may impact access to targeted therapies and immunotherapy. Although prior studies report variations in genetic alteration…